Extra-intestinal manifestations of Crohn's disease

被引:72
作者
Ephgrave, Kimberly [1 ]
机构
[1] Univ Iowa Hosp & Clin, Dept Surg, Iowa City, IA 52242 USA
关键词
D O I
10.1016/j.suc.2007.03.003
中图分类号
R61 [外科手术学];
学科分类号
摘要
Extra-intestinal manifestations occur in at least 25% of Crohn's disease patients. Some extra-intestinal manifestations, such as erythema nodusum and peripheral arthropathy, will wax and wane in keeping with bowel inflammation. The more severe cutaneous ulcerations, uveitis, and axial arthropathy may precede bowel disease or persist after it subsides. Screening may be appropriate for eye disease and for osteoporosis to prevent complications. Medical management for extra-intestinal manifestations is similar to treatment for the bowel symptoms of Crohn's disease, with corticosteroids the mainstay. Pain and depression are associated with inflammatory bowel disease, and their control benefits patients. Recent small studies with anti-tumor necrosis factor (TNF) agents are promising for most extra-intestinal manifestations of Crohn's disease, and may permit more steroid-sparing disease control in the future.
引用
收藏
页码:673 / +
页数:9
相关论文
共 38 条
[1]
Behcet's disease-like presentation of bullous pyoderma gangrenosum associated with Crohn's disease [J].
Akay, N ;
Boyvat, A ;
Heper, AO ;
Soykan, I ;
Arica, IE ;
Bektas, M ;
Ensari, A ;
Cokca, F .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2006, 31 (03) :384-386
[2]
Treatment of immune-mediated extraintestinal manifestations of inflammatory bowel disease with infliximab [J].
Barrie, Arthur ;
Plevy, Scott .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2006, 35 (04) :883-+
[3]
Bernstein Charles N, 2006, Curr Osteoporos Rep, V4, P116, DOI 10.1007/BF02686956
[4]
Bernstein CN, 2001, AM J GASTROENTEROL, V96, P1116
[5]
The clustering of other chronic inflammatory diseases in inflammatory bowel disease: A population-based study [J].
Bernstein, CN ;
Wajda, A ;
Blanchard, JF .
GASTROENTEROLOGY, 2005, 129 (03) :827-836
[6]
Abnormalities of uterine cervix in women with inflammatory bowel disease [J].
Bhatia, Jyoti ;
Bratcher, Jason ;
Korelitz, Burton ;
Vakher, Katherine ;
Mannor, Shlomo ;
Shevchuk, Maria ;
Panagopoulos, Gworgia ;
Ofer, Adam ;
Tamas, Ecaterina ;
Kotsali, Panayota ;
Vele, Oana .
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (38) :6167-6171
[7]
Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept [J].
Braun, J ;
Baraliakos, X ;
Listing, J ;
Sieper, J .
ARTHRITIS AND RHEUMATISM, 2005, 52 (08) :2447-2451
[8]
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial [J].
Brooklyn, TN ;
Dunnill, MGS ;
Shetty, A ;
Bowden, JJ ;
Williams, JDL ;
Griffiths, CEM ;
Forbes, A ;
Greenwood, R ;
Probert, CS .
GUT, 2006, 55 (04) :505-509
[9]
Danese S, 2006, WORLD J GASTROENTERO, V12, P4807
[10]
Analysis of risk factors for low bone mineral density in inflammatory bowel disease [J].
Frei, P ;
Frieda, M ;
Hungerbühler, V ;
Rammert, C ;
Rousson, V ;
Kullak-Ublick, GA .
DIGESTION, 2006, 73 (01) :40-46